STAT3 and glioblastoma: In a study, treatment of DMC prior to TMZ in glioblastoma cells resulted in a significant increase in caspase-3 signaling, mitochondria-related apoptosis and a marked inhibition of cell growth in vitro through production of ROS as well as inactivation of JAK/STAT3 signaling pathway [104].